Advertisement

Topics

Clinical Trial of ARQ 761 in Advanced Solid Tumors

2014-09-16 13:06:01 | BioPortfolio

Published on BioPortfolio: 2014-09-16T13:06:01-0400

Clinical Trials [7381 Associated Clinical Trials listed on BioPortfolio]

Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma

To define the toxicity and maximum-tolerated dose of weekly oral etoposide (VP-16) in patients with AIDS-related Kaposi's sarcoma; to determine the clinical pharmacology of orally administ...

4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases

The current Rethinking Clinical Trials (REaCT) trial will compare two schedules(12- vs. 4-weekly) of bone-targeting agents (BTAs) to evaluate quality of life, pain and skeletal events with...

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

An open label, dose-escalation study to evaluate safety, tolerability, maximum tolerated dose (MTD), efficacy, and pharmacokinetics (PKs) of CPI-613 given twice weekly for three consecutiv...

Weekly vs. Every 2 Week vs. Every 3 Week Administration of Abraxane/Bevacizumab Combination in Metastatic Breast Cancer

This is a multi-center, open-label, randomized Phase II study in previously untreated patients with metastatic breast cancer to evaluate the antitumor activity and safety of weekly dose-de...

Panitumumab Pediatric Study

This is an open-label, multi-center, single arm, dose-ranging, phase 1, clinical study. Panitumumab will be administered by IV infusion to 4-6 subjects per cohort. Three planned cohorts, ...

PubMed Articles [8298 Associated PubMed Articles listed on BioPortfolio]

Safety and Convenience of Once-Weekly Somapacitan in Adult GH Deficiency: A 26-Week Randomized, Controlled Trial.

Somapacitan is a reversible albumin-binding growth hormone (GH) derivative, developed for once-weekly administration. This study aimed to evaluate the safety of once-weekly somapacitan vs once-daily N...

Efficacy of weekly administration of paclitaxel and carboplatin for advanced ovarian cancer patients with poor performance status.

The aim of this study was to reveal the efficacy of weekly administration of paclitaxel and carboplatin for advanced ovarian cancer patients with poor performance status (PS).

Odanacatib Pharmacokinetics Comparison Between Chinese and Non-Chinese Postmenopausal Women.

Odanacatib (ODN), an oral selective inhibitor of cathepsin K, was an investigational agent previously in development for the treatment of osteoporosis. In this phase 1 open-label study, 12 healthy Chi...

Notes from the Field: Errors in Administration of an Excess Dosage of Yellow Fever Vaccine - United States, 2017.

Using Time-Referenced Data to Assess Medication Administration Performance and Quality.

This study tests the feasibility of using a large (big) clinical data set to test the ability to extract time-referenced data related to medication administration to identify late doses and as-needed ...

Medical and Biotech [MESH] Definitions

Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal.

The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.

The administration of drugs through the nasal passage.

Administration of a soluble dosage form by placement under the tongue.

The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.

More From BioPortfolio on "Clinical Trial of ARQ 761 in Advanced Solid Tumors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial